07:31 AM EST, 02/26/2025 (MT Newswires) -- Rhythm Pharmaceuticals ( RYTM ) reported Wednesday its Q4 loss widened to $0.72 per diluted share from $0.70 per share a year earlier.
Analysts polled by FactSet expected a loss of $0.69 per share.
Revenue for the quarter ended Dec. 31 was $41.8 million, up from $24.2 million a year earlier.
Analysts surveyed by FactSet expected $38.5 million.